[Therapy of moderate cognitive impairment and asthenia in patients with cerebrovascular pathology: results of a prospective observational study].
G I ShvartsmanA A SkorometsS A ZhivolupovOlga KurushinaS M KarpovN S BaranovaMarina S NesterovaI V SmaginaS V ProkopenkoE A AntipenkoL B NovikovaPublished in: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova (2022)
The nootropic medication Prospekta is effective and safe in treatment of MCI in patients with asthenia with CVD, and improves cognitive function in patients with asthenia with CVD, both in monotherapy and in combination with other nootropic agents.